Stereotactic Radiosurgery Combination With Anlotinib for Limited Brain Metastases in NSCLC
Clinical trial NCT04912128 · COMPLETED
Trial details
- NCT number
- NCT04912128
- Sponsor
- Peking University Third Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-01-15
- Primary completion
- 2021-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.